USPTO serial 90891399
PROTEUS
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- MCDOWELL, MATTHEW J
- Law office
- TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PROTEUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Culver City, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sara M. Bauer
Sara M. Bauer CHOATE HALL & STEWART LLPTWO INTERNATIONAL PLACEBOSTON, MA 02110UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for research and development of pharmaceutical preparations, biomolecular therapeutics, and medicines; downloadable software for research and development of biomolecules; downloadable software for the design and discovery of pharmaceutical preparations, biomolecular therapeutics, and medicines; downloadable software for the design and discovery of biomolecules; downloadable software for data analysis, pattern discovery, contextual prediction, predictive analytics, and predictive modelling for use in research and development of biomolecules; downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of biomolecules; downloadable software in the fields of molecular biology for chemical and molecular analysis prediction, identification, development, and discovery of molecular structures, pharmaceuticals, and medicines | ACTIVE | — |
| 042 | Design and development of customized artificial intelligence database software for others; research and development of software in the nature of a software module suite for the design and discovery of biomolecules; scientific and pharmaceutical artificial intelligence research services for others namely, development of artificial intelligence used to identify molecules and compounds for drug discovery and chemical development; software as a service (SAAS) services featuring software for research and development of pharmaceutical preparations, biomolecular therapeutics, and medicines; software as a services (SAAS) services featuring software for research and development of biomolecules; software as a services (SAAS) services featuring software for the design and discovery of pharmaceutical preparations, biomolecular therapeutics, and medicines; software as a service (SAAS) services featuring software for the design and discovery of biomolecules; software as a service (SAAS) services featuring software for data analysis, pattern discovery, contextual prediction, predictive analytics, and predictive modelling for use in research and development of biomolecules; software as a service (SAAS) services featuring software for searching, tracking, exploration and analysis of data for use in the research and development of biomolecules; software as a service (SAAS) services featuring software in the fields of molecular biology for chemical and molecular analysis prediction, identification, development, and discovery of molecular structures, pharmaceuticals, and medicines | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 22, 2022 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| Nov 22, 2022 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Nov 21, 2022 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jun 10, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 12, 2022 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Jan 12, 2022 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Oct 7, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 23, 2021 | NWAP | NEW APPLICATION ENTERED | — |